Showing results (131-140 of 173) with videos related to
Sort By:
Pageof 18
Seminars in Nuclear Medicine|March 31, 2010
Preclinical and clinical studies of peptide receptor radionuclide therapyStefan E Pool, Eric P Krenning, Gerben A Koning, et al.Journal of Cardiovascular Pharmacology|December 12, 2003
Site-specific intracoronary delivery of octreotide in humans: a pharmacokinetic study to determine dose-efficacy in restenosis preventionEdoardo Camenzind, Willem H Bakker, Ambroos Reijs, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2003
Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administrationBoen L R Kam, Roelf Valkema, Don Poldermans, et al.Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 geneSuzanne M Verwijnen, Peter A E Sillevis Smith, Rob C Hoeben, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Inhomogeneous localization of radioactivity in the human kidney after injection of [(111)In-DTPA]octreotideMarion De Jong, Roelf Valkema, Arthur Van Gameren, et al.Journal of Medicinal Chemistry|February 23, 2013
Gastrin releasing peptide receptor-directed radioligands based on a bombesin antagonist: synthesis, (111)in-labeling, and preclinical profilePanteleimon J Marsouvanidis, Berthold A Nock, Bouchra Hajjaj, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2009
Effects of therapy with [177Lu-DOTA 0,Tyr 3]octreotate on endocrine functionJaap J M Teunissen, Eric P Krenning, Frank H de Jong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survivalDik J Kwekkeboom, Wouter W de Herder, Boen L Kam, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 29, 2006
[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tateTheodosia Maina, Berthold A Nock, Paul Cordopatis, et al.Endocrine-Related Cancer|December 10, 2009
Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumorsDik J Kwekkeboom, Boen L Kam, Martijn van Essen, et al.Pageof 18